Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome: The STOPDAPT-2 ACS Randomized Clinical Trial.
Sign Up to like & getrecommendations! Published in 2022 at "JAMA cardiology"
DOI: 10.1001/jamacardio.2021.5244
Abstract: Importance Clopidogrel monotherapy after short dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) has not yet been fully investigated in patients with acute coronary syndrome (ACS). Objective To test the hypothesis of noninferiority of… read more here.
Keywords: dual antiplatelet; clopidogrel monotherapy; months dapt; antiplatelet therapy ... See more keywords
P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy After Deployment of a Drug-Eluting Stent
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.0877
Abstract: Key Points Question Is P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy (DAPT; a P2Y12 inhibitor plus aspirin) noninferior to 12 months of DAPT in terms of net adverse clinical events (a composite… read more here.
Keywords: inhibitor monotherapy; dual antiplatelet; p2y12 inhibitor;
Shorter Dual Antiplatelet Therapy for Older Adults After Percutaneous Coronary Intervention
Sign Up to like & getrecommendations! Published in 2024 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2024.4000
Abstract: Key Points Question What is the optimal duration of dual antiplatelet therapy (DAPT) in terms of net adverse clinical events, major cardiovascular events, and bleeding for older adults after percutaneous coronary intervention (PCI)? Findings In… read more here.
Keywords: months dapt; risk; adults percutaneous; dual antiplatelet ... See more keywords
Optimizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Older Adults.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA network open"
DOI: 10.1001/jamanetworkopen.2024.6951
Abstract: The observation by Colombo and colleagues 1 that dual antiplatelet therapy (DAPT), comprising aspirin and a P2Y12 antagonist, offers optimal antithrombotic protection following intracoronary stent implantation catalyzed the widespread adoption of intracoronary stents. Historically, stent… read more here.
Keywords: therapy; percutaneous coronary; month dapt; dual antiplatelet ... See more keywords
Safety and preliminary efficacy of argatroban plus dual antiplatelet therapy for acute mild to moderate ischemic stroke with large artery atherosclerosis
Sign Up to like & getrecommendations! Published in 2022 at "Brain and Behavior"
DOI: 10.1002/brb3.2664
Abstract: Previous studies suggest the benefit of dual antiplatelet therapy (DAPT) for acute ischemic stroke with large artery atherosclerosis (LAA) etiology, but there is no study about the effect of DAPT plus anticoagulant in this population. read more here.
Keywords: large artery; antiplatelet therapy; artery atherosclerosis; dual antiplatelet ... See more keywords
Short‐versus long‐term Dual Antiplatelet therapy after drug‐eluting stent implantation in women versus men: A sex‐specific patient‐level pooled‐analysis of six randomized trials
Sign Up to like & getrecommendations! Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26653
Abstract: Whether the efficacy and safety of dual antiplatelet therapy (DAPT) are uniform between sexes is unclear. We sought to compare clinical outcomes between short‐ (≤6 months) versus long‐term (≥1 year) DAPT after drug‐eluting stent (DES)… read more here.
Keywords: drug eluting; long term; dual antiplatelet; antiplatelet therapy ... See more keywords
Impact of six versus 12 months of dual antiplatelet therapy in patients with drug‐eluting stent implantation after risk stratification with the residual SYNTAX score: Results from a secondary analysis of the I‐LOVE‐IT 2 trial
Sign Up to like & getrecommendations! Published in 2017 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.26948
Abstract: The optimal duration of dual antiplatelet therapy (DAPT) after drug‐eluting stent (DES) implantation remains undetermined, especially for those at high risk of cardiac events postprocedure. read more here.
Keywords: drug eluting; dual antiplatelet; antiplatelet therapy; syntax ... See more keywords
Impact of dual antiplatelet therapy duration on 1‐year clinical outcomes in diabetic patients with acute coronary syndrome undergoing percutaneous coronary intervention: Insights from the real‐world OPT‐CAD study
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28653
Abstract: To investigate the optimal dual antiplatelet therapy (DAPT) duration for diabetic patients with acute coronary syndrome (ACS) after percutaneous coronary intervention (PCI). read more here.
Keywords: patients acute; dual antiplatelet; antiplatelet therapy; diabetic patients ... See more keywords
Three versus 12‐month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta‐analysis of randomized controlled trials
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30467
Abstract: The American Heart Association/American College of Cardiology guidelines on dual antiplatelet therapy (DAPT) recommend at least 12 months of a P2Y12 inhibitor and low dose aspirin in patients with an acute coronary syndrome (ACS) treated… read more here.
Keywords: coronary syndrome; randomized controlled; acute coronary; antiplatelet therapy ... See more keywords
Short‐term dual antiplatelet therapy for 1–3 months after percutaneous coronary intervention using drug eluting stents: A systematic review and meta‐analysis of randomized clinical trials
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30521
Abstract: The optimal dual antiplatelet therapy (DAPT) duration and regimen in patients undergoing percutaneous coronary intervention (PCI) using current generation drug eluting stents (DES) is still unclear. read more here.
Keywords: drug eluting; percutaneous coronary; eluting stents; coronary intervention ... See more keywords
Changes and innovations of the 2017 ESC guidelines on dual antiplatelet therapy in coronary artery disease—a review
Sign Up to like & getrecommendations! Published in 2018 at "Wiener klinische Wochenschrift"
DOI: 10.1007/s00508-018-1357-5
Abstract: SummaryDuration and compostion of dual antiplatelet therapy has been increasingly changed within the past few years as also indicated in the firmer ESC guidelines. The current manuscript summarizes the most important changes in dual antiplatelet… read more here.
Keywords: changes innovations; esc guidelines; dual antiplatelet; antiplatelet therapy ... See more keywords